The XpresSpa Group said it has signed a contract with the Port Authority of New York and New Jersey (PANYNJ) to provide diagnostic COVID-19 testing at Newark Liberty International Airport (EWR) through its XpresCheck brand.
The deal follows the successful launch in late June of the XpresCheck pilot program at John F. Kennedy International Airport (JFK) in the Arrivals Hall at Terminal 4.
“We are thrilled to be launching in Newark Liberty International Airport next week, which will be our second XpresCheck testing facility in the NY Metro area,” said Doug Satzman, XpresSpa CEO. “We are also hopeful that we can bring XpresCheck to additional U.S. airports over time, leveraging our learnings to date in setting up and administering a testing facility so that we can do our part to keep safe those who work in the airline industries as well as travelers.”
The XpresCheck facility at EWR Terminal B will feature six separate testing rooms with a capacity to administer over 350 tests per day. The location will initial offer testing services to airline employees, contractors and workers, concessionaires and their employees, TSA officers, and U.S. Customs and Border Protection agents, but over time, will expand to the traveling public as well.
The JFK XpresCheck last week began providing testing services to the public as well as airport workers, in part to help passengers traveling from select states and countries shorten the New York state-mandated 14-day quarantine, Satzman said.
